Apollon Builds Elite Advisory Board Ahead of FDA De Novo Program, Adding Harvard CGM Leader and BCG Veteran

MIT and Apollon Publish Clinical Validation of Needle-Free Continuous Glucose Monitor, Matching Accuracy of FDA-Cleared Devices

Apollon Fortifies Global IP Leadership in Metabolic Health with New U.S. Patents for Raman Spectroscopy-Based Non-Invasive CGM